Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.07.010Source: DataRank Database

Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid is a research paper published in Molecular Therapy — Methods & Clinical Development (2022). On theSindex it has a DataRank of 0. It has been cited 24 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access24 citations

Download PDF

Cite:

Linked data & code

bioproject gen uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.53)OA: goldTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Nick Goeden,Nicholas C. Flytzanis ORCID,Viviana Gradinaru ORCID,David Goertsen ORCID

Live enrichment

PubMed:35990749 PMC:PMC9372736 OpenAlex:https://openalex.org/W4289260770

Cystic Fibrosis Foundation

Grant: PCT/US21/46904

Cystic Fibrosis Foundation

Grant: CFF GOEDEN19F0

Defense Advanced Research Projects Agency

Grant: W911NF-17-2-0036

National Institutes of Health

Grant: DP1OD025535

Natural Sciences and Engineering Research Council of Canada

Grant: unidentified

unidentified

Natural Sciences and Engineering Research Council of Canada

FWCI

3.53

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2329050122001024/pdf

publisherhttp://www.cell.com/article/S2329050122001024/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2329050122001024?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2329050122001024?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.omtm.2022.07.010

Fields of Study

Virus-based gene therapy researchRNA Interference and Gene DeliveryViral gastroenteritis research and epidemiology0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

TransgeneCapsidGenetic enhancementLungGene deliveryTransduction (biophysics)Computational biologyBiologyMedicineVirologyCell biologyVirusGenePathologyBioinformaticsGeneticsInternal medicineBiophysicsDirected evolutionAdeno-associated virusAAVLung EpitheliumAtiiCapsid LibraryVector EngineeringAlveolar Epithelial Type IiQH573-671500610QH426-470Molecular MedicineOriginal ArticleCytologyMolecular Biology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Targeting the lung epithelium after intravenous delivery by directed evolution of underexplored sites on the AAV capsid

FAIR Checklist

Authors (4)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)